Table 7.
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of differentially expressed mRNA.
| Term | Genes | P-Value |
|---|---|---|
| Wnt signaling pathway | FZD8, CCND1, APC2, SFRP2, WIF1, FZD2, WNT7A, FZD4, FOSL1, MYC, FZD7 | <0.05 |
| Hippo signaling pathway | FZD8, CCND1, APC2, FZD2, GLI2, WNT7A, FZD4, MYC, FZD7 | <0.05 |
| Basal cell carcinoma | FZD8, APC2, FZD2, GLI2, WNT7A, FZD4, FZD7 | <0.05 |
| Notch signaling pathway | NOTCH3, HES1, NOTCH2, APH1A, DLL1, JAG1 | <0.05 |
| HTLV-I infection | FZD8, CCND1, APC2, FZD2, WNT7A, FZD4, FOSL1, MYC, FZD7 | <0.05 |
| Pathways in cancer | FZD8, CCND1, APC2, BCL2, FZD2, GLI2, WNT7A, FZD4, MYC, FZD7 | <0.05 |
| Proteoglycans in cancer | FZD8, CCND1, CD44, FZD2, WNT7A, FZD4, MYC, FZD7 | <0.05 |
| Signaling pathways regulating pluripotency of stem cells | FZD8, APC2, FZD2, WNT7A, FZD4, MYC, FZD7 | <0.05 |
| MicroRNAs in cancer | NOTCH3, NOTCH2, CCND1, CD44, APC2, BCL2, MYC | <0.05 |
| Melanogenesis | FZD8, FZD2, WNT7A, FZD4, FZD7 | <0.05 |
| Colorectal cancer | CCND1, APC2, BCL2, MYC | <0.05 |
| Thyroid hormone signaling pathway | NOTCH3, NOTCH2, CCND1, MYC | <0.05 |
| Endometrial cancer | CCND1, APC2, MYC | <0.05 |
| Small cell lung cancer | CCND1, BCL2, MYC | <0.05 |